Cancer is a global problem. Today, there is a 20% chance that cancer will be diagnosed in the course of a lifetime. Therefore, regular screening and the consequent biopsy procedure when exhibiting suspicious lesions have meanwhile become standard of care for different cancer types like breast, lung, colon or skin. Nevertheless, the current cancer diagnosis process remains slow and inefficient. Centralized labs require complex infrastructures and have high workflow maintenance costs. Moreover, the agonizing wait verifying that the detected lesion is benign or malignant can take up to several weeks. This causes unnecessary and extreme anxiety for the patient. The fact that more than 70% of patients who undergo a biopsy of suspicious lesions have a benign condition does not make waiting any better.